Jack Leslie chairs the NIH Clinical Center Research Hospital Board. He also serves as senior advisor at Weber Shandwick, the global PR firm that holds contracts with Pfizer, Moderna, GSK, Sanofi, Novartis, Eli Lilly, Johnson & Johnson, and Merck. When HHS Secretary Robert F. Kennedy Jr. opened a new vaccine injury clinic at the NIH, Leslie voted to rebuke it — then leaked the board's criticism to a New York Times reporter within hours.
The Times described him as an advisor to "WHO and philanthropies." No mention of the pharma payroll.
Paul D. Thacker, an investigative journalist at The DisinFormation Chronicle, first flagged Leslie's conflicts back in 2022. That was the same year Weber Shandwick landed a $50 million CDC contract and the same year former NIH Director Francis Collins appointed Leslie to the board. By 2024, Leslie had been elevated to chair. A Weber Shandwick employee's LinkedIn profile states the firm "focuses on boosting vaccination rates for flu, HPV, whooping cough, and COVID-19." That's not a side project. That's the business model.
So when Kennedy's vaccine injury clinic threatened to validate the idea that these products can hurt people, the man running Big Pharma's PR operation had a seat at the table where the official NIH response was drafted. He didn't just vote against the clinic. He made sure the story got to New York Times reporter Sheryl Gay Stolberg fast enough to frame the narrative before Kennedy's team could respond.
Stolberg's article ran with Leslie's criticism front and center. His credentials, as printed: advisor to WHO, board member of the Elizabeth Glaser Pediatric AIDS Foundation, affiliations with Duke University and Georgetown University. All true. All incomplete in a way that changes the entire story. Weber Shandwick — the firm that represents nearly every major vaccine manufacturer on earth — didn't make the cut.
The Times knew who Leslie was. Thacker had published the conflicts four years earlier, and they're not exactly hidden — Weber Shandwick's client list is public, and Leslie's role there is listed on his own professional biography. This wasn't a reporting failure. Reporters at that level don't accidentally omit the single most relevant fact about their source. They omit it because including it would make the source's criticism sound like exactly what it is: a PR operation protecting a client's product.
The NIH Clinical Center Research Hospital Board was established in 2016 as an advisory body. Advisory boards exist to provide independent oversight. The word "independent" does a lot of heavy lifting when the chair's employer collects fees from every company whose products the clinic might scrutinize. Leslie isn't advising the NIH. He's advising his clients from inside the NIH.
This is the machinery that makes vaccine skepticism sound like conspiracy theory. A pharma PR executive sits on the government board. The board issues a statement opposing accountability for vaccine injuries. A major newspaper runs the statement and scrubs the executive's industry ties. By the time the public reads it, the opposition to Kennedy's clinic looks like it's coming from serious, credentialed health policy experts — not from the people who get paid when vaccination rates go up.
Weber Shandwick's $50 million CDC contract. Leslie's appointment by Francis Collins. His elevation to chair. The leaked rebuke. Stolberg's story. One pipeline, five steps, zero disclosure.
The Times ran a correction last month for misspelling a city councilman's name. Jack Leslie's pharma career didn't rate the same treatment.
